Base modifying (BEAM) cures teenage woman’s T-cell Acute Lymphoblastic Leukemia : shares
https://www.bbc.com/information/health-63859184The article does not point out the corporate, however Beam Therapeutics (BEAM) is the one one ...
Read more
Tag: Beam
Beam Therapeutics (BEAM): Anticipated To Increase Pipeline Growth
asbe Beam Therapeutics (NASDAQ:BEAM) reported Q3 2022 EPS of -$1.56 lacking analysts' estimates by $0.47. It ...
Read morePremium Content
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.